{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T01:45:58Z","timestamp":1782870358363,"version":"3.54.5"},"reference-count":53,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010882","name":"TianJin Education Committee","doi-asserted-by":"publisher","award":["2022KJ251"],"award-info":[{"award-number":["2022KJ251"]}],"id":[{"id":"10.13039\/501100010882","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.isci.2025.113720","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:56:36Z","timestamp":1759798596000},"page":"113720","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["BPAG1 promotes osteoclastogenesis and postmenopausal osteoporosis via activating ERK signaling pathway"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3610-5229","authenticated-orcid":false,"given":"Yufeng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2025.113720_bib1","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s11657-018-0542-5","article-title":"FRAX\u00ae based intervention thresholds for management of osteoporosis in Singaporean women","volume":"13","author":"Chandran","year":"2018","journal-title":"Arch. Osteoporos."},{"key":"10.1016\/j.isci.2025.113720_bib2","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1056\/NEJMcp1513724","article-title":"Clinical Practice. Postmenopausal Osteoporosis","volume":"374","author":"Black","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2025.113720_bib3","doi-asserted-by":"crossref","first-page":"564","DOI":"10.4158\/GL-2020-0524","article-title":"AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS\/AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS- 2020 UPDATE EXECUTIVE SUMMARY","volume":"26","author":"Camacho","year":"2020","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.isci.2025.113720_bib4","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2025.113720_bib5","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1001\/jama.2018.6537","article-title":"Screening to Prevent Osteoporotic Fractures: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force","volume":"319","author":"Viswanathan","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.isci.2025.113720_bib6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/jbmr.534","article-title":"Bone mineral density loss in relation to the final menstrual period in a multiethnic cohort: results from the Study of Women's Health Across the Nation (SWAN)","volume":"27","author":"Greendale","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.isci.2025.113720_bib7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jsbmb.2013.09.008","article-title":"Prevention and treatment of postmenopausal osteoporosis","volume":"142","author":"Tella","year":"2014","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.isci.2025.113720_bib8","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41586-019-1105-7","article-title":"Developmental origin, functional maintenance and genetic rescue of osteoclasts","volume":"568","author":"Jacome-Galarza","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.isci.2025.113720_bib9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00774-020-01162-6","article-title":"Osteoclast differentiation by RANKL and OPG signaling pathways","volume":"39","author":"Udagawa","year":"2021","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.isci.2025.113720_bib10","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1186\/s13287-019-1500-x","article-title":"Aspirin inhibits RANKL-induced osteoclast differentiation in dendritic cells by suppressing NF-\u03baB and NFATc1 activation","volume":"10","author":"Wu","year":"2019","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.isci.2025.113720_bib11","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1172\/JCI200317215","article-title":"Role of RANK ligand in mediating increased bone resorption in early postmenopausal women","volume":"111","author":"Eghbali-Fatourechi","year":"2003","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.isci.2025.113720_bib12","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1210\/endo.140.10.7034","article-title":"Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis","volume":"140","author":"Hofbauer","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.isci.2025.113720_bib13","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.1210\/endo.140.9.7131","article-title":"Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells","volume":"140","author":"Hofbauer","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.isci.2025.113720_bib14","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S8756-3282(99)00162-3","article-title":"Interleukin-1beta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells","volume":"25","author":"Hofbauer","year":"1999","journal-title":"Bone"},{"key":"10.1016\/j.isci.2025.113720_bib15","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/46303","article-title":"Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand","volume":"402","author":"Kong","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.isci.2025.113720_bib16","doi-asserted-by":"crossref","first-page":"R59","DOI":"10.1172\/JCI10763","article-title":"Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection","volume":"106","author":"Teng","year":"2000","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.isci.2025.113720_bib17","doi-asserted-by":"crossref","first-page":"11581","DOI":"10.1073\/pnas.201394498","article-title":"Multiple myeloma disrupts the TRANCE\/osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression","volume":"98","author":"Pearse","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2025.113720_bib18","first-page":"4432","article-title":"Osteoprotegerin inhibits osteolysis and decreases skeletal tumor burden in syngeneic and nude mouse models of experimental bone metastasis","volume":"61","author":"Morony","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2025.113720_bib19","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41584-019-0172-3","article-title":"Antiresorptive and anabolic agents in the prevention and reversal of bone fragility","volume":"15","author":"Seeman","year":"2019","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.isci.2025.113720_bib20","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.eururo.2013.05.015","article-title":"Toxicities following treatment with bisphosphonates and receptor activator of nuclear factor-\u03baB ligand inhibitors in patients with advanced prostate cancer","volume":"65","author":"Gartrell","year":"2014","journal-title":"Eur. Urol."},{"key":"10.1016\/j.isci.2025.113720_bib21","doi-asserted-by":"crossref","first-page":"37","DOI":"10.7326\/M19-0533","article-title":"Long-Term Drug Therapy and Drug Discontinuations and Holidays for Osteoporosis Fracture Prevention: A Systematic Review","volume":"171","author":"Fink","year":"2019","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.isci.2025.113720_bib22","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/exd.12877","article-title":"One gene but different proteins and diseases: the complexity of dystonin and bullous pemphigoid antigen 1","volume":"25","author":"K\u00fcnzli","year":"2016","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.isci.2025.113720_bib23","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.cell.2008.07.045","article-title":"ACF7 regulates cytoskeletal-focal adhesion dynamics and migration and has ATPase activity","volume":"135","author":"Wu","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.isci.2025.113720_bib24","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1016\/j.yexcr.2006.04.025","article-title":"Dissecting the sequence specific functions of alternative N-terminal isoforms of mouse bullous pemphigoid antigen 1","volume":"312","author":"Jefferson","year":"2006","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.isci.2025.113720_bib25","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1523\/JNEUROSCI.1880-13.2014","article-title":"ACF7 is a hair-bundle antecedent, positioned to integrate cuticular plate actin and somatic tubulin","volume":"34","author":"Antonellis","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.isci.2025.113720_bib26","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cell.2010.12.033","article-title":"Skin stem cells orchestrate directional migration by regulating microtubule-ACF7 connections through GSK3\u03b2","volume":"144","author":"Wu","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.isci.2025.113720_bib27","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1016\/j.yexcr.2008.06.021","article-title":"Dystonin\/Bpag1 is a necessary endoplasmic reticulum\/nuclear envelope protein in sensory neurons","volume":"314","author":"Young","year":"2008","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.isci.2025.113720_bib28","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1091\/mbc.e11-06-0573","article-title":"Neuronal dystonin isoform 2 is a mediator of endoplasmic reticulum structure and function","volume":"23","author":"Ryan","year":"2012","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.isci.2025.113720_bib29","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1111\/ejn.12711","article-title":"Disruption of actin-binding domain-containing Dystonin protein causes dystonia musculorum in mice","volume":"40","author":"Horie","year":"2014","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.isci.2025.113720_bib30","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1083\/jcb.200012098","article-title":"The BPAG1 locus: Alternative splicing produces multiple isoforms with distinct cytoskeletal linker domains, including predominant isoforms in neurons and muscles","volume":"154","author":"Leung","year":"2001","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.isci.2025.113720_bib31","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1210\/jc.2016-1801","article-title":"Denosumab or Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates","volume":"101","author":"Miller","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.isci.2025.113720_bib32","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s40520-020-01708-8","article-title":"Role of bone-forming agents in the management of osteoporosis","volume":"33","author":"McClung","year":"2021","journal-title":"Aging Clin. Exp. Res."},{"key":"10.1016\/j.isci.2025.113720_bib33","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1177\/0192623317737066","article-title":"Antiresorptives: Safety Concerns-Clinical Perspective","volume":"45","author":"Brown","year":"2017","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.isci.2025.113720_bib34","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0140-6736(17)32137-2","article-title":"Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial","volume":"391","author":"Kendler","year":"2018","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.isci.2025.113720_bib35","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1210\/er.2004-0006","article-title":"Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use","volume":"26","author":"Hodsman","year":"2005","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.isci.2025.113720_bib36","doi-asserted-by":"crossref","first-page":"706","DOI":"10.14348\/molcells.2017.0225","article-title":"Current Understanding of RANK Signaling in Osteoclast Differentiation and Maturation","volume":"40","author":"Park","year":"2017","journal-title":"Mol. Cells"},{"key":"10.1016\/j.isci.2025.113720_bib37","first-page":"1997","article-title":"ERK\/MAPK signalling pathway and tumorigenesis","volume":"19","author":"Guo","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.isci.2025.113720_bib38","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13291","article-title":"Urolithin B suppressed osteoclast activation and reduced bone loss of osteoporosis via inhibiting ERK\/NF-\u03baB pathway","volume":"55","author":"Li","year":"2022","journal-title":"Cell Prolif."},{"key":"10.1016\/j.isci.2025.113720_bib39","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1016\/j.febslet.2011.07.046","article-title":"Naringin abrogates osteoclastogenesis and bone resorption via the inhibition of RANKL-induced NF-\u03baB and ERK activation","volume":"585","author":"Ang","year":"2011","journal-title":"FEBS Lett."},{"key":"10.1016\/j.isci.2025.113720_bib40","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/jcb.22800","article-title":"Mangiferin attenuates osteoclastogenesis, bone resorption, and RANKL-induced activation of NF-\u03baB and ERK","volume":"112","author":"Ang","year":"2011","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.isci.2025.113720_bib41","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.dental.2014.08.381","article-title":"Controlled-release naringin nanoscaffold for osteoporotic bone healing","volume":"30","author":"Ji","year":"2014","journal-title":"Dent. Mater."},{"key":"10.1016\/j.isci.2025.113720_bib42","doi-asserted-by":"crossref","first-page":"6337","DOI":"10.2147\/IJN.S456545","article-title":"pH-Responsive Mesoporous Silica Nanoparticles Loaded with Naringin for Targeted Osteoclast Inhibition and Bone Regeneration","volume":"19","author":"Gong","year":"2024","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.isci.2025.113720_bib43","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/odi.13745","article-title":"HIF-1\u03b1 regulates osteoclast activation and mediates osteogenesis during mandibular bone repair via CT-1","volume":"28","author":"Tian","year":"2022","journal-title":"Oral Dis."},{"key":"10.1016\/j.isci.2025.113720_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109095","article-title":"Advance in bone destruction participated by JAK\/STAT in rheumatoid arthritis and therapeutic effect of JAK\/STAT inhibitors","volume":"111","author":"Hu","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.isci.2025.113720_bib45","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13578-022-00813-7","article-title":"BHLHE40 promotes osteoclastogenesis and abnormal bone resorption via c-Fos\/NFATc1","volume":"12","author":"Zhang","year":"2022","journal-title":"Cell Biosci."},{"key":"10.1016\/j.isci.2025.113720_bib46","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S1674-8301(10)60009-7","article-title":"Construction and identification of recombinant lentiviral vector containing HIV-1 Tat gene and its expression in 293T cells","volume":"24","author":"Wei","year":"2010","journal-title":"J. Biomed. Res."},{"key":"10.1016\/j.isci.2025.113720_bib47","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/978-1-4939-2742-5_9","article-title":"The Western Blot","volume":"1318","author":"Hnasko","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.isci.2025.113720_bib48","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/978-1-4939-8994-2_29","article-title":"Description of Ovariectomy Protocol in Mice","volume":"1916","author":"Souza","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.isci.2025.113720_bib49","first-page":"11357","article-title":"Aberrant splicing in B-cell acute lymphoblastic leukemia","volume":"46","author":"Black","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2025.113720_bib50","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/ni.2419","article-title":"Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages","volume":"13","author":"Gautier","year":"2012","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.isci.2025.113720_bib51","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaf4238","article-title":"Specification of tissue-resident macrophages during organogenesis","volume":"353","author":"Mass","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.isci.2025.113720_bib52","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/ni.3320","article-title":"Tissue biology perspective on macrophages","volume":"17","author":"Okabe","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.isci.2025.113720_bib53","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.pharmthera.2017.02.017","article-title":"Macrophages and skeletal health","volume":"174","author":"Michalski","year":"2017","journal-title":"Pharmacol. Ther."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004225019819?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004225019819?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:59:13Z","timestamp":1782867553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004225019819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":53,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2589004225019819"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2025.113720","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BPAG1 promotes osteoclastogenesis and postmenopausal osteoporosis via activating ERK signaling pathway","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2025.113720","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"113720"}}